Eine Art planmäßiges Vorgehen - eine Anlagestrategie - ist unter Berücksichtigung von diversen Umständen und Risiken (Konjunkturlage, Börsentrend, Zinsentwicklung o. ä.) möglich. Aggressive Anleger setzen auf den schnellen Gewinn und häufige Umschichtung des Depots in schneller laufende Papiere (meist Optionsscheine). Konservativen Anlegern ist die Sicherheit wichtiger und das Depot ist meist mit risikoarmen Werten (Anleihen etc.) zur Erhaltung des Kapitals bestückt. http://www.ariva.de/extras/lexikon.m?begriff=Anlagestrategie
Total Cash (mrq): 1.52M Total Cash Per Share (mrq): 0.03 Total Debt (mrq): 119.36M Total Debt/Equity (mrq): N/A Current Ratio (mrq): 0.26 Book Value Per Share (mrq): 0.00 finance.yahoo.com/q/ks?s=IYXI+Key+Statistics
Inyx, Inc., through its wholly-owned subsidiaries, operates as a specialty pharmaceutical company in the United States, Canada, and Europe. It develops and manufactures prescription and over-the-counter pharmaceutical products. The company manufactures hydrocarbon aerosols, a delivery system for dermatological and topical drug applications; metered dose inhalers that are used for respiratory conditions; dry powdered inhalers used for respiratory ailments; metered dose nasal and throat pumps, and sprays; and sterile salines and injectables. It focuses on research and development activities on inhalation-therapy drug delivery devices and inhalation methods, and generic prescription, and over-the-counter aerosol pharmaceutical products for respiratory, allergy, dermatological, and topical and cardiovascular applications. The companyÂ’s proprietary products under development include generic versions of nonchlorofluorocarbon or hydrofluoroalkane single molecule and combination drug respiratory inhalants, nonCFC propelled oral sprays for cardiovascular ailments, wound irrigation, and cleansing sprays that utilize novel barrier technologies, and anti-inflammatory nasal pumps. It also provides specialty pharmaceutical development and manufacturing consulting services to the international healthcare market. The company was incorporated in 2000 and is based in New York, New York. finance.yahoo.com/q/pr?s=IYXI+Profile
Ex-drug company CEO charged in $100 mln fraud scheme in U.S. The former chief executive of defunct drug company Inyx Inc has been charged in connection with a fraud scheme that caused more than $100 million in losses and led to the collapse of one of Puerto Rico's largest banks, the U.S. Justice Department said on Friday. Jack Kachkar, 53, of Key Biscayne, Florida, was charged with eight counts of wire fraud in an indictment filed on Aug. 4 and unsealed on Friday, the department said in a news release. It said the scheme led to the closure of Westernbank Puerto Rico in April 2010. finance.yahoo.com/quote/IYXI?p=IYXI